• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】60097

【品名】2-[(2R)-1-(1H-indol-6-ylsulfonyl)pyrrolidinyl]-1-ethanol

【CA登记号】

【 分 子 式 】C14H18N2O3S

【 分 子 量 】294.3746

【元素组成】C 57.12% H 6.16% N 9.52% O 16.31% S 10.89%

与该中间体有关的原料药合成路线共 2 条

合成路线1

该中间体在本合成路线中的序号:(XII)

Oxidation of N-Boc-D-prolinol (I) with pyridinium dichromate affords aldehyde (II). This is subjected to Wittig condensation with methylene triphenylphosphorane to furnish N-Boc-2-vinylpyrrolidine (III). Hydroboration of (III) with 9-borabicyclononane, followed by oxidative work-up, leads to the primary alcohol (IV). Subsequent acidic Boc group cleavage in (IV) provides 2-pyrrolidinyl ethanol (V). Acylation of amine (V) with 4-methyl-3-nitrobenzenesulfonyl chloride (VI) gives sulfonamide (VII). The hydroxyl group of (VII) is further protected with methoxymethyl chloride, producing the methoxymethyl ether (VIII). Conversion of the ortho-nitrotoluene system (VIII) into indole (X) is then accomplished according to the Leimgruber-Batcho procedure, by condensation of (VIII) with dimethylformamide dimethylacetal, followed by reduction of the resultant nitro enamine (IX) with hydrazine in the presence of Raney nickel. Protection of the indole N of (X) with benzenesulfonyl chloride and NaH affords sulfonamide (XI). After acidic hydrolysis of the methoxymethyl protecting group of (XI), the N-phenylsulfonyl group is removed under alkaline conditions to yield indole (XII)

1 Forbes, I.T.; Gribble, A.D. (GlaxoSmithKline plc); Sulfonamide cpds., their preparation and use. WO 0262788 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 23310 tert-butyl (2R)-2-(hydroxymethyl)-1-pyrrolidinecarboxylate C10H19NO3 详情 详情
(II) 60087 tert-butyl (2R)-2-formyl-1-pyrrolidinecarboxylate C10H17NO3 详情 详情
(III) 60088 tert-butyl (2R)-2-vinyl-1-pyrrolidinecarboxylate C11H19NO2 详情 详情
(IV) 60089 tert-butyl (2R)-2-(2-hydroxyethyl)-1-pyrrolidinecarboxylate C11H21NO3 详情 详情
(V) 60090 2-[(2R)pyrrolidinyl]-1-ethanol C6H13NO 详情 详情
(VI) 60091 4-methyl-3-nitrobenzenesulfonyl chloride C7H6ClNO4S 详情 详情
(VII) 60092 2-{(2R)-1-[(4-methyl-3-nitrophenyl)sulfonyl]pyrrolidinyl}-1-ethanol C13H18N2O5S 详情 详情
(VIII) 60093 methoxymethyl 2-{(2R)-1-[(4-methyl-3-nitrophenyl)sulfonyl]pyrrolidinyl}ethyl ether; (2R)-2-[2-(methoxymethoxy)ethyl]-1-[(4-methyl-3-nitrophenyl)sulfonyl]pyrrolidine C15H22N2O6S 详情 详情
(IX) 60094 (E)-2-[4-({(2R)-2-[2-(methoxymethoxy)ethyl]pyrrolidinyl}sulfonyl)-2-nitrophenyl]-N,N-dimethyl-1-ethenamine; N-{(E)-2-[4-({(2R)-2-[2-(methoxymethoxy)ethyl]pyrrolidinyl}sulfonyl)-2-nitrophenyl]ethenyl}-N,N-dimethylamine C18H27N3O6S 详情 详情
(X) 60095 6-({(2R)-2-[2-(methoxymethoxy)ethyl]pyrrolidinyl}sulfonyl)-1H-indole; {2-[(2R)-1-(1H-indol-6-ylsulfonyl)pyrrolidinyl]ethoxy}methyl methyl ether C16H22N2O4S 详情 详情
(XI) 60096 6-({(2R)-2-[2-(methoxymethoxy)ethyl]pyrrolidinyl}sulfonyl)-1-(phenylsulfonyl)-1H-indole; methoxymethyl 2-((2R)-1-{[1-(phenylsulfonyl)-1H-indol-6-yl]sulfonyl}pyrrolidinyl)ethyl ether C22H26N2O6S2 详情 详情
(XII) 60097 2-[(2R)-1-(1H-indol-6-ylsulfonyl)pyrrolidinyl]-1-ethanol C14H18N2O3S 详情 详情

合成路线2

该中间体在本合成路线中的序号:(XII)

Conversion of alcohol (XII) into alkyl bromide (XIII) is carried out by treatment with carbon tetrabromide and triphenylphosphine. Then condensation of bromide (XIII) with 4-(4-chlorophenoxy)piperidine (XIV) in the presence of NaI and NaHCO3 produces the title compound

1 Forbes, I.T.; Douglas, S.; Gribble, A.D.; Ife, R.J.; Lightfoot, A.P.; Garner, A.E.; Riley, G.J.; Jeffery, P.; Stevens, A.J.; Stean, T.O.; Thomas, D.R.; SB-656104-A: A novel 5-HT(7) receptor antagonist with improved in vivo properties. Bioorg Med Chem Lett 2002, 12, 22, 3341.
2 Forbes, I.T.; Gribble, A.D. (GlaxoSmithKline plc); Sulfonamide cpds., their preparation and use. WO 0262788 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XII) 60097 2-[(2R)-1-(1H-indol-6-ylsulfonyl)pyrrolidinyl]-1-ethanol C14H18N2O3S 详情 详情
(XIII) 60098 6-{[(2R)-2-(2-bromoethyl)pyrrolidinyl]sulfonyl}-1H-indole C14H17BrN2O2S 详情 详情
(XIV) 60099 4-(4-chlorophenoxy)piperidine; 4-chlorophenyl 4-piperidinyl ether C11H14ClNO 详情 详情
Extended Information